Activity value 71united states Buyer&Supplier,Last transaction date:
2025-12-24
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for renibus therapeutics inc. from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 2 transactions, with a transaction quantity of 613 and a transaction weight of 0.
YearTransactionsQuantityWeight
202420.40
202526130
Bill of lading data
<
1/6
>
Trade date
2025/12/24
B/L No.
0338136
Suppliers
aragen life sciences pvt ltd.
Buyers
renibus therapeutics inc.
POLs
hyderabad
PODs
new york
Supply area
India
Purchas area
United States
Weight
——
Amount
4477.5
Hs code
70179090
Product tags
glass slide,tissue
Product description
TISSUE GLASS SLIDES H&E PAS AND C5B9 STAINING
Expand
Trade date
2025/12/24
B/L No.
4571817
Suppliers
aragen life sciences pvt ltd.
Buyers
renibus therapeutics inc.
renibus therapeutics inc. is united states Buyer&Supplier,
and primarily engages in the import and export business of products such as iron sucrose complex,bat.
According to the 52wmb.com global trade database, as of 2025-12-24, the company has completed 7 international trades,
with its main trading regions covering india etc.
The core products include HS29420090 etc,
often transported via new york,port charlotte, nc etc,
and its main trading partners are apothecon pharmaceuticals pvt ltd.,snj labs pvt ltd.,aragen life sciences pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on renibus therapeutics inc. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.